190 related articles for article (PubMed ID: 10413362)
21. Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.
Anderson GW; Rowland RR; Palmer GA; Even C; Plagemann PG
J Virol; 1995 Aug; 69(8):5177-85. PubMed ID: 7609091
[TBL] [Abstract][Full Text] [Related]
22. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
McDonald TL; Donnelly T; Weber A; Quenette L
Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
[TBL] [Abstract][Full Text] [Related]
23. Differential anti-Golgi complex autoantibody production following murine lactate dehydrogenase-elevating virus infection.
Nozawa K; Fritzler MJ; Ikeda K; Takasaki Y; Satoh M; Chan EK
Immunopharmacol Immunotoxicol; 2008; 30(1):13-25. PubMed ID: 18306101
[TBL] [Abstract][Full Text] [Related]
24. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
[TBL] [Abstract][Full Text] [Related]
25. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
Broen JB; Bradley DS; Powell KM; Cafruny WA
Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
Rowland RR; Butz EA; Plagemann PG
J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
[TBL] [Abstract][Full Text] [Related]
27. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
Morimoto M; Ohji T; Iwata H; Hayashi T
Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
[TBL] [Abstract][Full Text] [Related]
28. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
Weiland E; Weiland F; Grossmann A
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
[TBL] [Abstract][Full Text] [Related]
29. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
McDonald TL
Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
[TBL] [Abstract][Full Text] [Related]
30. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.
van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM
J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815
[TBL] [Abstract][Full Text] [Related]
31. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
[TBL] [Abstract][Full Text] [Related]
32. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.
Chen Z; Rowland RR; Anderson GW; Palmer GA; Plagemann PG
J Virol; 1997 Apr; 71(4):2913-20. PubMed ID: 9060649
[TBL] [Abstract][Full Text] [Related]
33. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.
Plagemann PG; Chen Z; Li K
Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706
[TBL] [Abstract][Full Text] [Related]
34. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
35. Lactic dehydrogenase virus inhibits allergic immunoglobulin E production: in vivo molecular analysis of cytokines.
Morimoto M; Iwata H; Hayashi T
Scand J Immunol; 1999 Aug; 50(2):211-4. PubMed ID: 10447927
[TBL] [Abstract][Full Text] [Related]
36. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons.
Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
J Gen Virol; 1995 Mar; 76 ( Pt 3)():581-92. PubMed ID: 7897349
[TBL] [Abstract][Full Text] [Related]
37. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
Plagemann PG
Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
[TBL] [Abstract][Full Text] [Related]
38. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
Gómez KA; Coutelier JP; Retegui LA
Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
[TBL] [Abstract][Full Text] [Related]
39. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus.
Cafruny WA; Plagemann PG
Infect Immun; 1982 Sep; 37(3):1007-12. PubMed ID: 7129627
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection.
Broen JJ; Cafruny WA
Reg Immunol; 1993; 5(1):44-52. PubMed ID: 8347469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]